Skip to content
healthcare.dev

Adrenal Liquescence 3001

NDC 63083-3001, Adrenal Liquescence, liquid, from Professional Complementary Health Formulas.

Product NDC
63083-3001
Status
Listed
Labeler
Professional Complementary Health Formulas
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63083-3001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCYRRHIZA GLABRA1 [hp_X]/118mL
  • BEE POLLEN2 [hp_X]/118mL
  • PAULLINIA CUPANA SEED3 [hp_X]/118mL
  • ROSA CANINA FRUIT3 [hp_X]/118mL
  • ASIAN GINSENG3 [hp_X]/118mL
  • SUS SCROFA ADRENAL GLAND6 [hp_X]/118mL
  • CORTICOTROPIN6 [hp_X]/118mL
  • EPHEDRA DISTACHYA FLOWERING TWIG6 [hp_X]/118mL
  • ZINC6 [hp_X]/118mL
  • EPINEPHRINE12 [hp_X]/118mL
  • SODIUM CHLORIDE12 [hp_X]/118mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
63083-3001-463083300104118 mL in 1 BOTTLE, DROPPER (63083-3001-4)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63083-3001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63083-3001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63083-3001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.